The Ins and Outs of Glaucoma Treatment in 2020: MIGS, LAsers, Drops and Depot

Continuing Medical Education (CME) Credits

Accreditation Statement

The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.

Designation Statement
The American Society of Cataract and Refractive Surgery designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Educational Objectives

Upon completion of the ASCRS The Ins and Outs of Glaucoma Treatment in 2020: MIGS, Lasers, Drops and Depot program, participants should be able to:

• Examine limitations of current eyedrop therapy and elucidate how laser, MIGS and sustained delivery address the unmet need created by problems with eyedrop therapy.

• Explain recent data on selective laser trabeculoplasty that support a role for laser early in the treatment paradigm.

• Describe the current available MIGS surgical options, including those that address the trabecular meshwork, the canal of Schlemm, and the subconjunctival outflow pathway.

• Recognize tips and surgical pearls for delivering excellent outcomes using MIGS with cataract surgery for glaucoma patients.

• Discuss glaucoma treatment strategies at different stages of disease, including integration of different treatment modalities, planning for possible future interventions and treatment side effect and complication considerations. 

Claim CME/CE Credits

Attendees will be able to evaluate The Ins and Outs of Glaucoma Treatment in 2020: MIGS, Lasers, Drops and Depot webinar electronically. At the conclusion of the program, attendees will be emailed a link to the program evaluation and credit claim. Please contact Janell John, ASCRS CME Coordinator, at  jjohn@ascrs.org with any questions on credit claims.

Notice About Off-Label Use Presentations
The ASCRS Inflammation and Pain webinar may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products or techniques presented.

ADA/Special Accommodations

ASCRS fully complies with the legal requirements of the American with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from its contracted vendors and facilities. Any participant in this educational program who requires special accommodations or services should contact a staff member.